- Home
- ALAR vs GNTA Comparison
ALAR vs GNTA Comparison
Compare ALAR & GNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- GNTA
- Stock Information
- Founded
- ALAR 2013
- GNTA 2014
- Country
- ALAR Israel
- GNTA Italy
- Employees
- ALAR N/A
- GNTA N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- GNTA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALAR Technology
- GNTA Health Care
- Exchange
- ALAR Nasdaq
- GNTA Nasdaq
- Market Cap
- ALAR 45.3M
- GNTA 81.2M
- IPO Year
- ALAR 2018
- GNTA 2021
- Fundamental
- Price
- ALAR $12.30
- GNTA $3.91
- Analyst Decision
- ALAR Strong Buy
- GNTA Strong Buy
- Analyst Count
- ALAR 1
- GNTA 1
- Target Price
- ALAR $15.00
- GNTA $25.00
- AVG Volume (30 Days)
- ALAR 162.4K
- GNTA 28.7K
- Earning Date
- ALAR 08-25-2025
- GNTA 01-01-0001
- Dividend Yield
- ALAR N/A
- GNTA N/A
- EPS Growth
- ALAR N/A
- GNTA N/A
- EPS
- ALAR 0.07
- GNTA N/A
- Revenue
- ALAR $30,581,000.00
- GNTA N/A
- Revenue This Year
- ALAR N/A
- GNTA N/A
- Revenue Next Year
- ALAR $12.28
- GNTA N/A
- P/E Ratio
- ALAR $19.30
- GNTA N/A
- Revenue Growth
- ALAR 4.67
- GNTA N/A
- 52 Week Low
- ALAR $5.45
- GNTA $2.74
- 52 Week High
- ALAR $37.19
- GNTA $7.28
- Technical
- Relative Strength Index (RSI)
- ALAR 55.68
- GNTA 55.67
- Support Level
- ALAR $13.20
- GNTA $3.69
- Resistance Level
- ALAR $14.63
- GNTA $3.94
- Average True Range (ATR)
- ALAR 1.01
- GNTA 0.29
- MACD
- ALAR -0.13
- GNTA 0.10
- Stochastic Oscillator
- ALAR 48.24
- GNTA 92.06
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About GNTA Genenta Science S.p.A.
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.